299 related articles for article (PubMed ID: 22011071)
21. Investigation of hydrophobically derivatized hyperbranched polyglycerol with PEGylated shell as a nanocarrier for systemic delivery of chemotherapeutics.
Misri R; Wong NK; Shenoi RA; Lum CM; Chafeeva I; Toth K; Rustum Y; Kizhakkedathu JN; Khan MK
Nanomedicine; 2015 Oct; 11(7):1785-95. PubMed ID: 25981338
[TBL] [Abstract][Full Text] [Related]
22. Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles.
Liu N; Ji J; Qiu H; Shao Z; Wen X; Chen A; Yao S; Zhang X; Yao H; Zhang L
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):305-314. PubMed ID: 31858836
[TBL] [Abstract][Full Text] [Related]
23. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
[TBL] [Abstract][Full Text] [Related]
25. Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery.
Karve S; Werner ME; Sukumar R; Cummings ND; Copp JA; Wang EC; Li C; Sethi M; Chen RC; Pacold ME; Wang AZ
Proc Natl Acad Sci U S A; 2012 May; 109(21):8230-5. PubMed ID: 22547809
[TBL] [Abstract][Full Text] [Related]
26. ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.
Wang AZ; Yuet K; Zhang L; Gu FX; Huynh-Le M; Radovic-Moreno AF; Kantoff PW; Bander NH; Langer R; Farokhzad OC
Nanomedicine (Lond); 2010 Apr; 5(3):361-8. PubMed ID: 20394530
[TBL] [Abstract][Full Text] [Related]
27. Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation.
Gan CW; Chien S; Feng SS
Curr Pharm Des; 2010 Jul; 16(21):2308-20. PubMed ID: 20618152
[TBL] [Abstract][Full Text] [Related]
28. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
29. Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.
Werner ME; Karve S; Sukumar R; Cummings ND; Copp JA; Chen RC; Zhang T; Wang AZ
Biomaterials; 2011 Nov; 32(33):8548-54. PubMed ID: 21843904
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy.
Chu KS; Schorzman AN; Finniss MC; Bowerman CJ; Peng L; Luft JC; Madden AJ; Wang AZ; Zamboni WC; DeSimone JM
Biomaterials; 2013 Nov; 34(33):8424-9. PubMed ID: 23899444
[TBL] [Abstract][Full Text] [Related]
31. Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy.
Tao W; Zhang J; Zeng X; Liu D; Liu G; Zhu X; Liu Y; Yu Q; Huang L; Mei L
Adv Healthc Mater; 2015 Jun; 4(8):1203-14. PubMed ID: 25800699
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel with concurrent radiotherapy in head and neck cancer.
Nabell L; Spencer S
Semin Oncol; 2003 Dec; 30(6 Suppl 18):89-93. PubMed ID: 14727247
[TBL] [Abstract][Full Text] [Related]
33. Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy.
Zhang X; Liu N; Shao Z; Qiu H; Yao H; Ji J; Wang J; Lu W; Chen RC; Zhang L
Nanomedicine; 2017 May; 13(4):1309-1321. PubMed ID: 28185938
[TBL] [Abstract][Full Text] [Related]
34. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Liu Y; Li K; Pan J; Liu B; Feng SS
Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
[TBL] [Abstract][Full Text] [Related]
35. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.
Kolishetti N; Dhar S; Valencia PM; Lin LQ; Karnik R; Lippard SJ; Langer R; Farokhzad OC
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):17939-44. PubMed ID: 20921363
[TBL] [Abstract][Full Text] [Related]
36.
Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
[TBL] [Abstract][Full Text] [Related]
37. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment.
Pan J; Liu Y; Feng SS
Nanomedicine (Lond); 2010 Apr; 5(3):347-60. PubMed ID: 20394529
[TBL] [Abstract][Full Text] [Related]
38. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
[No Abstract] [Full Text] [Related]
39. Extra cellular pH influences uptake and photodynamic action of pyropheophorbide-a entrapped in folate receptor targeted organically modified silica nanoparticle.
Singh SP; Sharma M; Patel H; Gupta PK
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):156-64. PubMed ID: 24594209
[TBL] [Abstract][Full Text] [Related]
40. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.
Valencia PM; Hanewich-Hollatz MH; Gao W; Karim F; Langer R; Karnik R; Farokhzad OC
Biomaterials; 2011 Sep; 32(26):6226-33. PubMed ID: 21658757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
